epicatechin has been researched along with tannins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazinet, L; Cao, S; Christensen, KA; Clardy, J; Cryan, LM; Habeshian, KA; Rogers, MS | 1 |
| Jayaprakash, V; Murtuja, S; Sarkar, B; Shilkar, D; Sinha, BN | 1 |
1 review(s) available for epicatechin and tannins
| Article | Year |
|---|---|
A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Cysteine Endopeptidases; Dengue Virus; Humans; Protease Inhibitors; SARS-CoV-2 | 2021 |
1 other study(ies) available for epicatechin and tannins
| Article | Year |
|---|---|
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Humans; Hydrolyzable Tannins; Mice; Neovascularization, Pathologic; Receptors, Peptide | 2013 |